Introduction to Ibrance (Palbociclib) 125mg
Ibrance (Palbociclib) 125mg is a prescription oncology medicine used in the treatment of certain types of breast cancer, particularly hormone receptor-positive (HR+), HER2-negative advanced or metastatic breast cancer. Palbolib 125 Capsule, a generic version, contains the same active ingredient, providing similar therapeutic effects under medical supervision.
Ibrance (Palbociclib) 125mg is classified under Prescription Medicines, Oncology Medicines, Anticancer Drugs, and Targeted Cancer Therapy. It works by blocking specific proteins that promote cancer cell growth and division.
What Is Ibrance (Palbociclib)?
Ibrance is the brand name for Palbociclib, an oral targeted therapy widely used for the treatment of advanced breast cancer.
Palbociclib belongs to a class of medicines known as CDK4/6 Inhibitors. These medicines help slow down cancer cell growth by interfering with cell cycle progression.
Generic versions such as Palbolib 125 Capsule may be used depending on physician recommendation and availability.
Drug Class and Mechanism of Action
Palbociclib is classified as a cyclin-dependent kinase (CDK) 4/6 inhibitor with strong antineoplastic properties.
How Palbociclib Works
- Inhibits CDK4 and CDK6 enzymes responsible for cell division
- Blocks progression of cancer cells from G1 to S phase
- Slows tumor growth and proliferation
- Enhances effectiveness of hormonal therapies
How Ibrance Works in the Body
After oral administration, Palbociclib targets cancer cells and prevents them from multiplying, helping to control tumor growth and spread.
Key Actions of Palbociclib
- Slows cancer cell division
- Enhances hormone therapy effectiveness
- Controls tumor progression
- Supports long-term cancer management
Palbolib 125 Capsule delivers the same active compound, providing similar targeted cancer therapy under professional supervision.
Medical Uses of Ibrance (Palbociclib) 125mg
Ibrance for Breast Cancer
Ibrance 125mg is commonly used in combination with endocrine therapy (such as letrozole or fulvestrant) for advanced breast cancer.
Potential Benefits
- Improved progression-free survival
- Slower disease progression
- Better response when combined with hormone therapy
Generic alternatives like Palbolib 125 Capsule may also be used under medical supervision.
Who Can Take Palbolib 125 Capsule?
This medicine should only be taken under the supervision of a qualified healthcare provider.
Eligibility Criteria
Patients may be prescribed Ibrance or Palbolib if they:
- Have HR-positive, HER2-negative advanced breast cancer
- Are suitable for combination hormone therapy
- Can follow regular monitoring and blood tests
Who Should Avoid Ibrance (Palbociclib) 125mg
Ibrance should NOT be used by:
- Pregnant or breastfeeding women
- Individuals with hypersensitivity to Palbociclib
- Patients with severe uncontrolled infections or very low blood cell counts
Ibrance (Palbociclib) 125mg Dosage and Administration
Standard Dosage Guidelines
- Typical dose: 125mg once daily for 21 consecutive days, followed by 7 days off (28-day cycle)
- Capsules should be swallowed whole with food
- Must be taken at the same time each day
Dosage Adjustments
Doctors may adjust the dose depending on:
- Blood test results (neutropenia, leukopenia)
- Liver function
- Patient tolerance and treatment response
Side Effects of Palbolib 125 Capsule
Common Side Effects
- Fatigue and weakness
- Nausea
- Hair thinning
- Diarrhea or mouth sores
Serious Side Effects
- Neutropenia (low white blood cells)
- Increased risk of infections
- Lung inflammation (rare)
- Severe fatigue or anemia
Patients should report any unusual symptoms to their doctor immediately.
Storage:
Store below 25°C in a cool, dry place, protected from moisture and direct sunlight. Keep capsules in original packaging and out of reach of children.
Frequently Asked Questions (FAQs)
1. Is Palbolib 125 Capsule chemotherapy?
No. It is a targeted therapy (CDK4/6 inhibitor), not traditional chemotherapy.
2. How long is treatment with Palbolib 125 Capsule?
Treatment continues as long as the cancer is controlled and side effects are manageable.
3. Can Palbolib be taken alone?
It is usually taken with hormone therapy like letrozole or fulvestrant.
4. Can pregnant women take Palbolib 125 Capsule?
No. It may cause harm to the unborn baby.
5. Is Palbolib 125 Capsule the same as Ibrance?
Yes. It contains Palbociclib, the same active ingredient as Ibrance.
6. Do I need a prescription to buy Palbolib 125 Capsule?
Yes. It is a prescription-only oncology medicine and must be used under specialist supervision.
Medical Disclaimer
The information provided is for educational purposes only and should not be considered medical advice. Ibrance (Palbociclib) is a prescription-only medicine and must be used under qualified healthcare supervision. Always consult your physician before starting, stopping, or changing any medication.
